Zycov-D gets Emergency Approval: First Vaccine for Above 12

  • The Drug Controller General has granted emergency approval to the Zycov-D, a COVID-19 vaccine developed by the Ahmedabad-based Zydus Cadilla group.
  • It the first vaccine in India that can be administered to adults as well as those 12 and above.
  • It is also the only DNA-based vaccine in the world and can be administered without a needle, purportedly minimising chances of reactions.
  • Interim results from Phase-III Clinical Trials showed a primary efficacy of 66.6% for symptomatic RT-PCR positive cases.